[HTML][HTML] Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit

F Brites, M Martin, I Guillas, A Kontush - BBA clinical, 2017 - Elsevier
Uptake of low-density lipoprotein (LDL) particles by macrophages represents a key step in
the development of atherosclerotic plaques, leading to the foam cell formation. Chemical …

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on

LG Costa, G Giordano, CE Furlong - Biochemical pharmacology, 2011 - Elsevier
Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated enzyme displaying
esterase and lactonase activity. PON1 hydrolyzes several organophosphorus (OP) …

Paraoxonase: a multifaceted biomolecule

B Goswami, D Tayal, N Gupta, V Mallika - Clinica Chimica Acta, 2009 - Elsevier
BACKGROUND: Paraoxonase enzyme was first identified as a protective barrier against
organophosphorus poisoning. After painstaking research spanning the last three decades …

Variation in paraoxonase-1 activity and atherosclerosis

H Soran, NN Younis, V Charlton-Menys… - Current opinion in …, 2009 - journals.lww.com
Variation in paraoxonase-1 activity and atherosclerosis : Current Opinion in Lipidology
Variation in paraoxonase-1 activity and atherosclerosis : Current Opinion in Lipidology Log in or …

The relationship between cancer and paraoxonase 1

IM Medina-Díaz, N Ponce-Ruíz, AE Rojas-García… - Antioxidants, 2022 - mdpi.com
Extensive research has been carried out to understand and elucidate the mechanisms of
paraoxonase 1 (PON1) in the development of diseases including cancer, cardiovascular …

Modulatory effect of lifestyle-related, environmental and genetic factors on paraoxonase-1 activity: a review

D Kunachowicz, M Ściskalska, M Kepinska - International Journal of …, 2023 - mdpi.com
Paraoxonase-1 (PON1) is a calcium-dependent, HDL-bound serum hydrolase active toward
a wide variety of substrates. PON1 displays three types of activities, among which lactonase …

Statins: neurobiological underpinnings and mechanisms in mood disorders

AJ Walker, Y Kim, I Borissiouk, R Rehder… - Neuroscience & …, 2021 - Elsevier
Abstract Statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) treat
dyslipidaemia and cardiovascular disease by inhibiting cholesterol biosynthesis. They also …

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia

SK Kota, LK Meher, SK Kota, S Jammula… - Indian journal of …, 2013 - journals.lww.com
Abstract Human serum paraoxonase 1 (PON1) is an enzyme with esterase activity, and is
physically bound to high-density lipoproteins (HDL). It plays a key role in the action of HDL …

Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions

S Yamashita, K Tsubakio-Yamamoto… - … of atherosclerosis and …, 2010 - jstage.jst.go.jp
HDL is a lipoprotein that plays a central role in reverse cholesterol transport (RCT). Hypo-
HDL-cholesterolemia has long been recognized as a strong and independent risk factor for …

Effect of carotenoids on paraoxonase-1 activity and gene expression

A Otocka-Kmiecik - Nutrients, 2022 - mdpi.com
Paraoxonase 1 (PON1) is an antioxidant enzyme attached to HDL with an anti-atherogenic
potential. It protects LDL and HDL from lipid peroxidation. The enzyme is sensitive to various …